Based on a licensing agreement with the German Center for Neurodegenerative Diseases (DZNE) and the Leibniz Institute of Polymer Research Dresden (IPF), the Dresden-based start-up Neuron-D is developing a high-throughput system for testing drug candidates against neurodegenerative diseases.

The technology is based on a process jointly developed by the DZNE and IPF for the production of three-dimensional cell cultures. The resulting cell cultures can be tailored to simulate either the situation in the healthy brain or under disease conditions, depending on the requirements. This enables the simulation of key features of neurons in the human brain and the disease process associated with neurodegeneration much better than with previous methods.

Further information:
https://www.bionity.com/de/news/1170370/erstes-spin-off-des-dzne-nutzt-innovative-technologie-um-arzneistoffe-zu-testen.html